SCHEMBL6126089

SCHEMBL6126089

CC1(C)OB(c2ccc3c(c2)CCc2nc(C4CCCN4C(=O)O)[nH]c2-3)OC1(C)C

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 15/20 0.32
HCRTR2 O43614 15/20 0.32
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
ROCK1 Q13464 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15397697 0.89 USP30 (0.39) PRMT5WDR77
SCHEMBL6128999 0.89 USP30 (0.39) PRMT5WDR77
SCHEMBL6126424 0.89 USP30 (0.39) PRMT5WDR77
SCHEMBL14691240 0.85 USP30 (0.39) PRMT5WDR77
SCHEMBL14691241 0.85 USP30 (0.39) PRMT5WDR77
SCHEMBL6127148 0.84 CYP3A4 (0.53) CYP3A4
SCHEMBL7602110 0.84 CYP3A4 (0.53) CYP3A4
SCHEMBL6126731 0.83 HCRTR1 (0.42) HCRTR1HCRTR2
SCHEMBL15390368 0.81
SCHEMBL750855 0.81 HCRTR1 (0.46) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640719-A2 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2013-09-25 EP disclosed
EP-2580209-A2 INHIBITORS OF HCV NS5A PROTEIN Presidio Pharmaceuticals, Inc. (US) 2013-04-17 EP disclosed
WO-2012068234-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-05-24 WO disclosed
WO-2011156543-A2 INHIBITORS OF HCV NS5A PROTEIN PRESIDIO PHARMACEUTICALS, INC. (US) 2011-12-15 WO disclosed